1-20 of 43
Zhuoxin Sun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial

James M. Foran, Li Chen, Selina M Luger, Zhuoxin Sun, Heidi Klepin, David F. Claxton, Hillard M. Lazarus, Jacob M. Rowe, Jessica K. Altman, Aref Al-Kali, Hong Zheng, Keith W Pratz, Edward R. Broun, Bayard L Powell, Kristen M. O'Dwyer, Yishai Ofran, John E. Godwin, Mark R. Litzow, Martin S. Tallman, Lynne Wagner
Journal: Blood
Blood (2023) 142 (Supplement 1): 594.
https://doi.org/10.1182/blood-2023-189734
Published: 2023
Journal Articles

Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial

Selina M Luger, Zhuoxin Sun, Ryan J Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang, Janis Racevckis, Hillard M. Lazarus, Jacob M. Rowe, Daniel A. Arber, Matthew J. Wieduwilt, Michaela Liedtke, Julie Bergeron, Brent L. Wood, Yaqi Zhao, Gang Wu, Ti-Cheng Chang, Wenchao Zhang, Keith W Pratz, Shira N. Dinner, Noelle V. Frey, Steven D. Gore, Bhavana Bhatnagar, Ehab L. Atallah, Geoffrey L Uy, Deepa Jeyakumar, Tara L Lin, Cheryl L. Willman, Daniel J. DeAngelo, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M Stone, Charles G. Mullighan, Mark R. Litzow, Martin S. Tallman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2877.
https://doi.org/10.1182/blood-2023-189648
Published: 2023
Journal Articles

A Pro-Inflammatory Gene Signature Characterizes a Better Risk Aged AML Patient Group in ECOG-ACRIN Cancer Research Group's Clinical Trial E3999

Yaseswini Neelamraju, Franck Rapaport, Jorge A Gandara, Nicholas Dunham, Hao Fan, Tak Lee, Subhash Prajapati, Caroline Sheridan, Ling Wang, Larry D. Cripe, Richard Dillon, Maria Kleppe, Ross L Levine, Christopher Mason, Ari M Melnick, Elisabeth Paietta, Gail J. Roboz, Zhuoxin Sun, Martin S. Tallman, Yanming Zhang, Stefan Bekiranov, Francine E. Garrett-Bakelman
Journal: Blood
Blood (2023) 142 (Supplement 1): 4326.
https://doi.org/10.1182/blood-2023-179569
Published: 2023
Journal Articles

Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial

Mark R. Litzow, Zhuoxin Sun, Elisabeth Paietta, Ryan J. Mattison, Hillard M Lazarus, Jacob M. Rowe, Daniel A. Arber, Charles G. Mullighan, Cheryl L Willman, Yanming Zhang, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Keith W. Pratz, Shira Dinner, Noelle V. Frey, Steven D. Gore, Bhavana Bhatnagar, Ehab L. Atallah, Geoffrey L. Uy, Deepa Jeyakumar, Tara L. Lin, Richard F. Little, Selina M. Luger, Martin S. Tallman
Journal: Blood
Blood (2022) 140 (Supplement 2): LBA-1.
https://doi.org/10.1182/blood-2022-171751
Published: 2022
Journal Articles

Allogeneic Transplantation in Fit Older Adults Is Feasible and Encouragingly Efficacious. Post Remission Data from the Prospective ECOG-ACRIN (E2906) Clinical Study

Yishai Ofran, Zhuoxin Sun, Jacob M. Rowe, David F. Claxton, Martin S. Tallman, Daniel A. Arber, Ari Melnick, Ross L. Levine, Elisabeth Paietta, John E. Godwin, Hillard M Lazarus, Selina M. Luger, James M. Foran, Mark R. Litzow
Journal: Blood
Blood (2021) 138 (Supplement 1): 413.
https://doi.org/10.1182/blood-2021-149356
Published: 2021
Journal Articles

Patients with AML Who Achieve Long Term Complete Remission Do Not Have a Normal Life Expectancy When Compared to the General Population. Analysis of 3,012 Patients Enrolled on 9 Consecutive ECOG-ACRIN Trials

Chezi Ganzel, Kevin Roopcharan, Zhuoxin Sun, Jacob M. Rowe, Hugo F Fernandez, Elisabeth M. Paietta, Selina M. Luger, Hillard M Lazarus, Larry D Cripe, Dan Douer, Peter H. Wiernik, Martin S. Tallman, Mark R. Litzow
Journal: Blood
Blood (2021) 138 (Supplement 1): 690.
https://doi.org/10.1182/blood-2021-149208
Published: 2021
Journal Articles

Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

Sara Zarnegar-Lumley, MD, Todd A. Alonzo, PhD, Megan Othus, PhD, Zhuoxin Sun, PhD, Rhonda E. Ries, MA, Yi-Cheng Wang, MS, Amanda R. Leonti, MS, Matthew A. Kutny, MD, Derek Stirewalt, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Era L Pogosova-Agadjanyan, BS, Kristen Marie O'Dwyer, MD, Harry P. Erba, MD PhD, Omar Abdel-Wahab, MD, Martin S. Tallman, MD, Mark Litzow, MD, Ehab L. Atallah, MD, Selina M. Luger, MD FRCPC, Ross L. Levine, MD, Todd M. Cooper, DO, Alan S. Gamis, MD MPH, Richard Aplenc, MD PhD, Anders E. Kolb, MD, Soheil Meshinchi, MDPhD, Katherine Tarlock, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-134211
Published: 2020
Journal Articles

Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study

James M. Foran, MD, Zhuoxin Sun, David F. Claxton, MD, Hillard M Lazarus, MD, Daniel A. Arber, MD, Jacob M. Rowe, MB, BS, Elisabeth Paietta, PhD, Janis Racevskis, PhD, Jessica K. Altman, Selina M. Luger, MD FRCPC, Aref Al-Kali, MD, Hong Zheng, MD PhD, Keith W. Pratz, MD, Edward R. Broun, MD, Bayard L Powell, MD, Kristen Marie O'Dwyer, MD, John E. Godwin, MD, Yishai Ofran, MD, Mark Litzow, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 115.
https://doi.org/10.1182/blood-2019-129876
Published: 2019
Journal Articles

Phase II Randomized Trial of Gilteritinib Vs Midostaurin in Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AML)

Selina M. Luger, MD FRCPC, Zhuoxin Sun, PhD, Sanam Loghavi, MD, Hillard M Lazarus, MD, Jacob M. Rowe, MB, BS, Martin S. Tallman, MD, Keith W. Pratz, MD, Mark Litzow, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1309.
https://doi.org/10.1182/blood-2019-128377
Published: 2019
Journal Articles

Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Results of the E2905 Intergroup Phase III Study - an ECOG-ACRIN Cancer Research Group Study, Grant CA180820, and the National Cancer Institute of the National Institutes of Health

Alan F. List, MD, Zhuoxin Sun, PhD, Amit Verma, MBBS, John M. Bennett, MD, Kathy McGraw, PhD, Jaroslaw P. Maciejewski, MD PhD, Rami S. Komrokji, MD, Timothy R. Wassenaar, MD, Selina M. Luger, MD FRCPC, Ryan J. Mattison, MD, Puneet S. Cheema, MD, Jessica K. Altman, David F. Claxton, MD, Charles A. Schiffer, MD, Andrew S. Artz, MD, Mark Litzow, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 842.
https://doi.org/10.1182/blood-2019-127274
Published: 2019
Journal Articles

Minimal Residual Disease (MRD) at Time of Complete Remission Is Commonly Detected in Acute Myeloid Leukemia (AML) Patients Age ≥60 Years and Significantly Impacts Outcome Based on Post-Remission Treatment Strategies: Prospective Analysis of ECOG-ACRIN (E-A) E2906 Phase III Trial

James M. Foran, MD, Zhuoxin Sun, PhD, Elisabeth Paietta, PhD, Janis Racevskis, PhD, David F. Claxton, MD, Hillard M Lazarus, MD, Daniel A. Arber, MD, Jacob M. Rowe, MD, Jessica K. Altman, MD, Aref Al-Kali, MD, Hong Zheng, MDPhD, Keith W. Pratz, MD, Edward R. Broun, MD, Bayard L. Powell, MD, Kristen Marie O'Dwyer, MD, John Godwin, MD, Yanming Zhang, MD, Martin S. Tallman, MD, Selina Luger, MD, Mark R. Litzow, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 437.
https://doi.org/10.1182/blood-2018-99-113950
Published: 2018
Journal Articles

FLT3-ITD Mutations Are Prevalent and Significantly Impact Outcome after Intensive Therapy in Elderly Adults with Acute Myeloid Leukemia (AML): Analysis of the North American Intergroup E2906 Phase III Trial in Patients Age ≥60 Years

James M. Foran, MD, Zhuoxin Sun, PhD, Elisabeth Paietta, PhD, Janis Racevskis, PhD, David F. Claxton, MD, Hillard M Lazarus, MD, Daniel A. Arber, MD, Jacob M. Rowe, MD, John Godwin, MD, Yanming Zhang, MD, Martin S. Tallman, MD, Mark R. Litzow, MD, Keith W. Pratz, MD, Selina Luger, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3995.
https://doi.org/10.1182/blood-2018-99-117838
Published: 2018
Journal Articles

Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614)

Jun Yin, PhD, Geoffrey L. Uy, MD, Betsy Laplant, MS, Elizabeth Storrick, Guido Marcucci, Hugo F. Fernandez, MD, Zhuoxin Sun, PhD, Mark R. Litzow, MD, Megan Othus, PhD, Frederick R. Appelbaum, MD, Richard A. Larson, MD, Richard M. Stone, MD, Sumithra J Mandrekar, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1386.
https://doi.org/10.1182/blood-2018-99-113902
Published: 2018
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study

Celalettin Ustun, MD, Jennifer Le-Rademacher, PhD, Hai-Lin Wang, MPH, Megan Othus, Zhuoxin Sun, PhD, Brittny Major, Mei-Jie Zhang, PhD, Elizabeth Storrick, Jacqueline M Lafky, Selina Chow, Krzysztof Mrózek, MD PhD, Eyal C. Attar, MD, Clara D. Bloomfield, MD, Larry D Cripe, MD, Richard A. Larson, MD, Guido Marcucci, Gail J. Roboz, MD, Geoffrey L. Uy, MD, Richard M. Stone, MD, Aminah Jatoi, Thomas C. Shea, MD, Marcos de Lima, MD, James M. Foran, MD, Brenda M. Sandmaier, MD, Mark R. Litzow, MD, Harry P. Erba, MD PhD, Arti Hurria, MD, Daniel J. Weisdorf, MD, Andrew S Artz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2170.
https://doi.org/10.1182/blood-2018-99-118383
Published: 2018
Journal Articles

Genomic Landscapes in Elderly AML

Franck Rapaport, PhD, Timour Baslan, PhD, Ling Wang, MS, Caroline Sheridan, Tak Lee, Todd Hricik, Marc Robert de Massy, Leonid Telis, Yaseswini Neelamraju, Juan Medina, Larry D Cripe, MD, Martin S. Tallman, MD, Scott Lowe, PhD, Zhuoxin Sun, PhD, Yanming Zhang, MD, Donna S. Neuberg, ScD, Elisabeth Paietta, PhD, Ari Melnick, MD, Ross L. Levine, MD, Maria Kleppe, PhD, Francine E. Garrett-Bakelman, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 404.
https://doi.org/10.1182/blood.V130.Suppl_1.404.404
Published: 2017
Journal Articles

Importance of Achieving Complete Remission (CR) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults Age ≥60 Years: Analysis of Risk Factors for Early Mortality and Re-Induction, and Impact of Quality of Response on Overall Survival (OS) in the ECOG-ACRIN E2906 Randomized Trial

James M. Foran, MD, Zhuoxin Sun, PhD, David F. Claxton, MD, Hillard M. Lazarus, MD, Mary L. Thomas, RN, MS, Ari Melnick, MD, Ross L. Levine, MD, Elisabeth Paietta, PhD, Daniel A. Arber, MD, Yanming Zhang, MD, Jacob M. Rowe, MD, John E. Godwin, Jessica K Altman, MD, Selina Luger, MD, Aref Al-Kali, MD, Hong Zheng, MD PhD, Keith W. Pratz, MD, E. Randolph Broun, MD, Bayard L Powell, MD, Kristen O'Dwyer, MD, Mark Litzow, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2016) 128 (22): 339.
https://doi.org/10.1182/blood.V128.22.339.339
Published: 2016
Journal Articles

Combined Treatment with Lenalidomide (LEN) and Epoetin Alfa (EA) Is Superior to Lenalidomide Alone in Patients with Erythropoietin (Epo)-Refractory, Lower Risk (LR) Non-Deletion 5q [Del(5q)] Myelodysplastic Syndrome (MDS): Results of the E2905 Intergroup Study-an ECOG-ACRIN Cancer Research Group Study, Grant CA180820, and the National Cancer Institute of the National Institutes of Health

Alan F List, MD, Zhuoxin Sun, PhD, Amit Verma, MD, John M. Bennett, MD, Kathy L McGraw, PhD, Lisa Ann Nardelli, BS, Jaroslaw P Maciejewski, MD PhD FACP, Jessica K Altman, MD, Puneet Cheema, MD, David F. Claxton, MD, Rami S. Komrokji, MD, Selina Luger, MD, Ryan Mattison, MD, Tim Wassenaar, MD, Andrew Artz, MD, Charles A Schiffer, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2016) 128 (22): 223.
https://doi.org/10.1182/blood.V128.22.223.223
Published: 2016
Journal Articles

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups

Clinical Trials & Observations
Marlise R. Luskin, Ju-Whei Lee, Hugo F. Fernandez, Omar Abdel-Wahab, John M. Bennett, Rhett P. Ketterling, Hillard M. Lazarus, Ross L. Levine, Mark R. Litzow, Elisabeth M. Paietta, Jay P. Patel, Janis Racevskis, Jacob M. Rowe, Martin S. Tallman, Zhuoxin Sun, Selina M. Luger
Journal: Blood
Blood (2016) 127 (12): 1551–1558.
https://doi.org/10.1182/blood-2015-07-657403
Published: 2016
Includes: Supplemental data
Journal Articles

A Clinical Measure of DNA Methylation Predicts Outcome in De Novo AML

Marlise R. Luskin, MD, Phyllis Gimotty, PhD, Catherine Smith, Alison Loren, MD MS, Maria Figueroa, MD, Jenna Harrison, Zhuoxin Sun, PhD, Martin S Tallman, MD, Elisabeth Paietta, PhD, Mark R Litzow, MD, Ross L. Levine, MD, Hugo F. Fernandez, MD, Selina Luger, MD, Martin Carroll, MD, Stephen Master, MD PhD, Gerald Wertheim, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2591.
https://doi.org/10.1182/blood.V126.23.2591.2591
Published: 2015
Journal Articles

North American Leukemia, Intergroup Phase III Randomized Trial of Single Agent Clofarabine As Induction and Post-Remission Therapy, and Decitabine As Maintenance Therapy in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age ≥60 Years): A Trial of the ECOG-ACRIN Cancer Research Group (E2906)

James M. Foran, MD, Zhuoxin Sun, PhD, David F. Claxton, MD, Hillard M. Lazarus, MD, Mary L. Thomas, RN, MS, Ari Melnick, MD, Ross L. Levine, MD, Elisabeth Paietta, PhD, Daniel Arber, Yangming Zhang, MD, Jacob M. Rowe, MD, John E. Godwin, MD MS, Jessica K. Altman, MD, Selina Luger, MD, Aref Al-Kali, MD, Hong Zheng, MD PhD, Keith Pratz, MD, E. Randolph Broun, MD, Bayard L. Powell, MD, Kristen O'Dwyer, MD, Mark R Litzow, MD, Martin S Tallman, MD
Journal: Blood
Blood (2015) 126 (23): 217.
https://doi.org/10.1182/blood.V126.23.217.217
Published: 2015